Delayed antiretroviral therapy initiation
Delayed antiretroviral therapy initiation has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, Feb 10, 2026: “Survival outcomes of older people living with HIV from 2001 to 2020 in Hunan, China: a retrospective cohort study”.
1 paper studies it1 findingUpdated
See all 1 papers on delayed antiretroviral therapy initiation
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“not initiating antiretroviral therapy within 30 days of diagnosis (HR = 1.284, 95% CI: 1.209–1.363) were also associated with a higher risk of all-cause mortality”
- 1 lab in 1 country
- Funders: Centers for Disease Control and Prevention and 1 more
- Humans1
What is delayed antiretroviral therapy initiation linked with?
1Studies link delayed antiretroviral therapy initiation with mortality.
Mortality
upin humans1HR 1.284
1 study
Mortality
upin humans1HR 1.284
Delayed antiretroviral therapy initiation is linked with a higher risk of mortality in older people living with HIV (HR = 1.284, 95% CI: 1.209–1.363).
“not initiating antiretroviral therapy within 30 days of diagnosis (HR = 1.284, 95% CI: 1.209–1.363) were also associated with a higher risk of all-cause mortality”
Humansin older people living with HIV
BMC public health